Cargando…
BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
BRG1 is one of two catalytic subunits of the SWI/SNF ATP-dependent chromatin-remodeling complex. In cancer, it has been hypothesized that BRG1 acts as a tumor suppressor. Further study has shown that, under certain circumstances, BRG1 acts as an oncogene. Targeted knockout of BRG1 has proven success...
Autores principales: | Shaykevich, Aaron, Silverman, Isaac, Bandyopadhyaya, Gargi, Maitra, Radhashree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917617/ https://www.ncbi.nlm.nih.gov/pubmed/36769189 http://dx.doi.org/10.3390/ijms24032869 |
Ejemplares similares
-
On the Interaction Between SMARCAL1 and BRG1
por: Bisht, Deepa, et al.
Publicado: (2022) -
The BRG1 transcriptional coregulator
por: Trotter, Kevin W., et al.
Publicado: (2008) -
BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness
por: Kaufmann, Benedikt, et al.
Publicado: (2017) -
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
por: Giles, Katherine A., et al.
Publicado: (2021) -
BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation
por: Marathe, Himangi G., et al.
Publicado: (2017)